Stephen James Moore

Person

Livermore, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 12,139,816
- Issue date Nov 12, 2024
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Humanized anti-complement factor Bb antibodies and uses thereof
- Patent number 11,999,780
- Issue date Jun 4, 2024
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 11,884,746
- Issue date Jan 30, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloproteinase substrates and other cleavable moieties an...
- Patent number 11,814,410
- Issue date Nov 14, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,944
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,943
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,472,875
- Issue date Oct 18, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized anti-complement factor Bb antibodies
- Patent number 11,242,382
- Issue date Feb 8, 2022
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 11,198,864
- Issue date Dec 14, 2021
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of inducing complement activity
- Patent number 11,192,944
- Issue date Dec 7, 2021
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 11,174,316
- Issue date Nov 16, 2021
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,046,759
- Issue date Jun 29, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 11,028,126
- Issue date Jun 8, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 10,947,531
- Issue date Mar 16, 2021
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,669,339
- Issue date Jun 2, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind interleukin-6 receptor and methods...
- Patent number 10,611,845
- Issue date Apr 7, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 10,336,824
- Issue date Jul 2, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 10,138,272
- Issue date Nov 27, 2018
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 9,562,073
- Issue date Feb 7, 2017
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable antibodies that bind interleukin-6 receptor and methods...
- Patent number 9,487,590
- Issue date Nov 8, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 9,309,510
- Issue date Apr 12, 2016
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20250034755
- Publication date Jan 30, 2025
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20240391986
- Publication date Nov 28, 2024
- Genzyme Corporation
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20240150402
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240150478
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240084022
- Publication date Mar 14, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230212283
- Publication date Jul 6, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230021301
- Publication date Jan 19, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20220411470
- Publication date Dec 29, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20220380453
- Publication date Dec 1, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20220298245
- Publication date Sep 22, 2022
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20220235351
- Publication date Jul 28, 2022
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20220213179
- Publication date Jul 7, 2022
- Genzyme Corporation
- Graham Parry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210355208
- Publication date Nov 18, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20210347886
- Publication date Nov 11, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF
- Publication number 20210332115
- Publication date Oct 28, 2021
- Genzyme Corporation
- Graham Parry
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF QUALITATIVELY AND/OR QUANTITATIVELY ANALYZING PROPERTIES...
- Publication number 20210025877
- Publication date Jan 28, 2021
- CytomX Therapeutices, Inc.
- Olga VASILJEVA
- G01 - MEASURING TESTING
Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20200339976
- Publication date Oct 29, 2020
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...
- Publication number 20200339694
- Publication date Oct 29, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF INDUCING COMPLEMENT ACTIVITY
- Publication number 20200239556
- Publication date Jul 30, 2020
- Bioverativ USA Inc.
- Sandip Panicker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20200231677
- Publication date Jul 23, 2020
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20190382493
- Publication date Dec 19, 2019
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20190284283
- Publication date Sep 19, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20190241652
- Publication date Aug 8, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20190135864
- Publication date May 9, 2019
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20170204139
- Publication date Jul 20, 2017
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...
- Publication number 20170002082
- Publication date Jan 5, 2017
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...
- Publication number 20160311903
- Publication date Oct 27, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20160289324
- Publication date Oct 6, 2016
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20160264961
- Publication date Sep 15, 2016
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20150218217
- Publication date Aug 6, 2015
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stephen James Moore

Person

Patents Grantslast 30 patents

Protease-resistant systems for polypeptide display and methods of m...

Humanized anti-complement factor Bb antibodies and uses thereof

Matriptase and u-plasminogen activator substrates and other cleavab...

Matrix metalloproteinase substrates and other cleavable moieties an...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Humanized anti-complement factor Bb antibodies

Protease-resistant systems for polypeptide display and methods of m...

Methods of inducing complement activity

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matriptase and u-plasminogen activator substrates and other cleavab...

Protease-resistant systems for polypeptide display and methods of m...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Activatable antibodies that bind interleukin-6 receptor and methods...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Matriptase and u-plasminogen activator substrates and other cleavab...

Matriptase and u-plasminogen activator substrates and other cleavab...

Activatable antibodies that bind interleukin-6 receptor and methods...

Protease-resistant systems for polypeptide display and methods of m...

Patents Applicationslast 30 patents

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

METHODS OF QUALITATIVELY AND/OR QUANTITATIVELY ANALYZING PROPERTIES...

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...

METHODS OF INDUCING COMPLEMENT ACTIVITY

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS...

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...